These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15627788)

  • 21. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.
    Nakashima A; Yorioka N; Mizutani T; Yamagata Z; Ueno T; Takasugi N
    Nephron Clin Pract; 2005; 99(3):c78-85. PubMed ID: 15665550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Bone resorption marker; urinary and serum CTX].
    Gorai I
    Clin Calcium; 2006 Jun; 16(6):1001-8. PubMed ID: 16751697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
    Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
    J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
    Franke S; Lehmann G; Abendroth K; Hein G; Stein G
    Eur J Med Res; 1998 Feb; 3(1-2):81-8. PubMed ID: 9512973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma serotonin and markers of bone formation and bone resorption in hemodialysis patients.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Sparopoulou T; Stefanidis I; Galaktidou G
    Iran J Kidney Dis; 2013 Jan; 7(1):36-41. PubMed ID: 23314140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
    Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretion of parathyroid hormone oscillates depending on the change in serum ionized calcium during hemodialysis and may affect bone metabolism.
    Kitahara T; Ueki K; Kuroiwa T; Kaneko Y; Hiromura K; Nojima Y
    Nephron Clin Pract; 2005; 101(1):c9-17. PubMed ID: 15886497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure].
    Oliveri B; Wittich AC; Nadal MA; Zeni SN
    Medicina (B Aires); 2005; 65(4):321-8. PubMed ID: 16193710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
    Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A
    J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
    Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y
    Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
    Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.